Salvia BioElectronics
Company · Eindhoven, Netherlands
Developing a thin, flexible implant under the scalp that stimulates nerves to prevent chronic migraine.
In the news
NeuromodulationClinical trials
Salvia BioElectronics implants first US patient in RECLAIM-II migraine implant study
Dutch company Salvia BioElectronics has started RECLAIM-II, a randomized, double-blind US study of its ultra-thin MySalvia scalp implants for hard-to-treat migraine, with plans to enroll 150 people.